Medplus Health Services profit and loss

Latest FY26

Revenue: ₹6,892cr+12.3% on FY25
EBITDA: ₹607cr+24.7% on FY25
Net profit: ₹220cr+46.2% on FY25
EPS: ₹18.33+45.8% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	7,587	6,892	6,136	5,625	4,558	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	79.2	71.3	48.6	40.0	46.1
	7,666	6,964	6,185	5,665	4,604
	88.1	88.7	61.7	44.5	25.9
	5,804	5,030	4,572	4,538	3,753
	−242	−34.6	6.5	−191	−221
	963	885	726	626	545
	134	120	103	96.4	83.0
	310	283	250	224	182
	343	316	282	254	189
	7,401	6,688	6,001	5,591	4,556
	631	607	487	354	266
	321	324	237	130	84.1
Profit
	266	275	183	73.4	47.2
	266	275	183	73.4	47.2
	73.6	77.7	47.9	27.1	18.1
	−19.0	−21.9	−14.9	−19.2	−21.0
	54.7	55.7	33.1	7.9	−2.9
	211	220	150	65.6	50.1
	211	220	150	65.6	50.1
	2.9	2.2	0.1	−0.1	0.3
	214	222	150	65.5	50.4
	211	220	150	65.5	49.8
	−0.0	−0.0	−0.1	0.1	0.3
Per share
	₹17.64	₹18.33	₹12.57	₹5.48	₹4.17
	₹17.62	₹18.29	₹12.52	₹5.45	₹4.17
Other comprehensive income — detail
	2.9	2.2	0.1	—	—
	—	2.7	0.2	0.0	0.5
	0.7	0.5	0.1	—	—
	—	—	—	0.1	0.1
	214	222	150	65.4	50.1
	−0.0	−0.0	−0.1	0.1	0.3
Per share — as-filed variants
	₹17.64	₹18.33	₹12.57	₹5.48	₹4.17
	₹17.62	₹18.29	₹12.52	₹5.45	₹4.17
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	1,937	1,808	1,495	1,233	1,000
	25.5%	26.2%	24.4%	21.9%	21.9%
Adjusted (ex-exceptional items) — derived
	266	275	183	73.4	47.2
	211	220	150	65.6	50.1
	₹17.64	₹18.33	₹12.57	₹5.48	₹4.17

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDPLUS₹598.05

Medplus Health Services Ltd.

· Consumer Services

Annual Quarterly₹ CrorePeersAPOLLOHOSP MANYAVAR MSTCLTD NESCO JUSTDIAL JSLL QUESS IXIGOMcap ₹7,180 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	4,557.6	5,624.9	6,136.1	6,892.5	7,587.2
Other Income	46.1	40.0	48.6	71.3	79.2
Total Income	4,603.7	5,664.9	6,184.7	6,963.8	7,666.4
Expenses
+ Cost of Materials Consumed	25.9	44.5	61.7	88.7	88.1
+ Purchases of Stock-in-Trade	3,752.9	4,537.9	4,572.5	5,030.5	5,804.4
+ Changes in Inventories	-221.1	-190.8	6.5	-34.6	-242.3
+ Employee Benefit Expense	545.1	625.5	726.0	884.5	962.7
+ Finance Costs	83.0	96.4	102.6	120.5	134.2
+ Depreciation & Amortisation	181.6	224.2	249.8	282.9	310.4
+ Other Expenses	189.1	253.6	282.3	316.0	343.3
Total Expenses	4,556.5	5,591.4	6,001.4	6,688.5	7,400.8
EBITDA	265.7	354.1	487.1	607.4	631.1
EBIT	84.1	129.9	237.3	324.5	320.6
Profit
PBT before Exceptional Items	47.2	73.4	183.3	275.3	265.7
Pretax Income	47.2	73.4	183.3	275.3	265.7
+ Current Tax	18.1	27.1	47.9	77.7	73.6
+ Deferred Tax	-21.0	-19.2	-14.9	-21.9	-19.0
Tax Expense	-2.9	7.9	33.1	55.7	54.7
Net Income	50.1	65.6	150.2	219.6	211.0
+ Net Income — Continuing Ops	50.1	65.6	150.2	219.6	211.0
+ Other Comprehensive Income	0.3	-0.1	0.1	2.2	2.9
Total Comprehensive Income	50.4	65.5	150.4	221.8	213.9
Net Income to Common	49.8	65.5	150.3	219.6	211.0
Minority Interest	0.3	0.1	-0.1	-0.0	-0.0
Per Share
Basic EPS	4.17	5.48	12.57	18.33	17.64
Diluted EPS	4.17	5.45	12.52	18.29	17.62
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.1	2.2	2.9
+ Items NOT to be Reclassified to P&L	0.5	0.0	0.2	2.7	—
+ Tax on Items NOT to be Reclassified	—	—	0.1	0.5	0.7
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.1	—	—	—
Comprehensive Income — Owners of Parent	50.1	65.4	150.5	221.8	213.9
Comprehensive Income — Non-controlling Interests	0.3	0.1	-0.1	-0.0	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	4.17	5.48	12.57	18.33	17.64
Diluted EPS — Continuing Operations	4.17	5.45	12.52	18.29	17.62
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	999.9	1,233.2	1,495.4	1,807.9	1,937.0
Gross Margin %	21.94	21.92	24.37	26.23	25.53
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	47.2	73.4	183.3	275.3	265.7
Net Income Adj (tax-effected)	50.1	65.6	150.2	219.6	211.0
EPS Adj	4.17	5.48	12.57	18.33	17.64
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	23.9	23.9	23.9	24.0	24.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.